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37.76% and 11.31%. From 2010 to 2012, the average hospitalization expenses of 
each visit with BMISE was 25575.34, 24219.22 and 26889.57 yuan; For BMISUR, the 
expenses of each visit was 21211.57, 18999.53 and 19088.96 yuan. Reimbursement by 
BMISE in 2010, 2011 and 2012 was 71.01%, 74.12% and 68.25%; while the reimburse-
ment by BMISUR was 45.95%, 53.49% and 51.16%. ConClusions: The insurance 
level difference between two health insurance schemes influences the treatment 
regimens and benefits received by patients. People prefer to go to third-level hospi-
tals, but people with BMISE has higher proportion than people with BMISUR, about 
10%. For the people with BMISUR, the out-of-pocket spending was 50% of total 
expenses, needing to raise reimbursement rate, setting up differentiated reimburse-
ment for different income level groups. From 2011 to 2012, the reimbursement rate 
declined slowly, we need to study the cause in the future.
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objeCtives: According to Canada, US and European guidelines and the Helsingborg 
Declaration, all eligible stroke patients should receive care in specialized stroke 
centers. During the last decade, partly due to the Alberta Provincial Stroke Strategy 
(APSS), 16 stroke centers were established in Alberta. This study examined the effect 
of admission to stroke centers on mortality for patients with ischemic stroke, com-
pared with admission to non-stroke centers. Methods: The study population was 
identified from the Discharge Abstract Database (DAD) from the province of Alberta, 
Canada. We included stoke patients with most response diagnostic code I63 (ICD10) 
with a first admission to acute care hospitals between April 1st 2004 and March 
31st 2011. Disease specific co-morbidities were adapted from the literature review, 
including secondary diagnoses in the DAD. We utilized the triage information from 
National Ambulatory Care Report System (NACRS) as the proxy of disease severity. 
The average marginal effect of stroke center on the 30-days in-hospital mortality 
was estimated in a bivariate probit model, using differential distance to hospitals as 
an instrumental variable to correct potential pre-hospital selection bias, adjusting 
for age, sex, co-morbidities, and disease severity. Results: Among 9152 patients, 
6405 (70%) were admitted to stroke centers (n= 16) and 2747 (30%) to non-stroke 
centers. The overall unadjusted 30-day all-cause mortality rate was 9.8% for patients 
first admitted to stroke centers and 11.1% for patients admitted to non-designated 
hospitals. Adjusting patient characteristics and other factors, we found first admis-
sion to a stroke center was associated with a 6.4% (95%CI: -1.2%, -11.5%) absolute 
reduction in 30-day all-cause in-hospital mortality compared to non-stroke cent-
ers. ConClusions: In an observational study, we provided new evidence to sup-
port the role of stroke center on the reduction in mortality in a universal publicly 
funded health care system.
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objeCtives: Although previous studies have shown that stroke centers reduce 
mortality in patients with ischemic stroke, the association between stroke cent-
ers and reduction in length of stay (LOS) in hospital has not been demonstrated. 
We sought to evaluate the impact of stroke centres as designated by the Alberta 
Provincial Stroke Strategy (APSS) in Alberta on the LOS of acute ischemic stroke 
patients. Methods: We compared the actual LOS during the first episode of hos-
pitalization for patients with acute ischemic stroke admitted first to designated 
stroke centers or non-stroke centers between April 1st 2004 and March 31st 2011 
using the Alberta Hospital Discharge Abstracts Database. Using propensity score 
methods, we applied a log linear regression model to estimate the average change 
in LOS for all ischemic patients and the change for the patients admitted to the 
stroke centers, adjusting for age, sex, co-morbidities, disease severity, discharge 
type and being in the alternate level of care. Results: Among 9,092 patients, 6,360 
(70%) were admitted to stroke centers. The prolonged hospital stay with alternate 
level of care designation had occurred in 1,572 (17.3%) of patients. The number of 
patients discharged to home, home with support or other health care facility, or 
died were 3,767(41.4%) 4,159(45.7%), and 1,166 (12.8%), respectively. The average 
unadjusted LOS was 21.3 (SD= 33.9) days for patients admitted to stroke centers 
and 24.8 (SD= 37.5) days for patients admitted to non-stroke centers. Adjusting 
for the patient characteristics and other factors, we estimated that the average 
LOS was reduced by 6.5% (95%CI: -12.3%, -0.6%) for patients first admitted to 
stroke centers compared with non-stroke centers. ConClusions: The study 
shows that in patients with acute ischemic stroke, first admission to stroke cent-
ers had significantly reduced LOS compared with non-stroke centers in Alberta 
by about 1.4 days.
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objeCtives: Medicaid coverage among non-elderly adults is often characterized by 
drop-outs and churning – entering and exiting Medicaid – over short durations. Little 
is known about the impact of such disruptions in Medicaid coverage on health care 
resources utilization and adherence to cardiovascular and lipid-lowering medica-
tions among enrollees with cardiovascular disease (CVD). Methods: This was a 
retrospective, repeated cross-sectional study design employing data from 2002-2011 
Medical Expenditure Panel Survey. Study sample included adults aged 18-64 years 
diagnosed with ≥ 1 CVD or associated comorbidity who reported having Medicaid 
coverage any time during survey year. Individuals with CVD having continuous, full-
year Medicaid coverage (N= 1,624) were compared to those with < 12 months of cov-
erage (N= 3,394). Medication adherence was calculated as proportion of days covered 
by refills of any CVD medication class examined during the reference period, capped 
at 1, and analyzed using ordinary least squares regression and multivariate logistic 
regression. Utilization of 5 CVD-specific health care resources – inpatient, emer-
gency (ER), outpatient, and office-based physician visits, and prescription medica-
tions – were estimated using zero-inflated negative binomial models controlling for 
sociodemographic, health status, disease burden, and Medicaid eligibility covariates, 
and year fixed effects. Results: Older age, White race, higher income, intermit-
tent employment, any private insurance were significant predictors of Medicaid 
discontinuity (P< 0.05). Individuals experiencing discontinuity in Medicaid coverage 
were predicted to have 0.03 more inpatient (P< 0.01), 0.03 more ER (P< 0.001), and 0.24 
less office-based physician visits (P< 0.05), and 0.02 more prescription medications 
(P< 0.05), all other things being equal. Medication adherence was not significantly 
different between the two groups, nor was it a significant predictor in most outcome 
models. ConClusions: Individuals with CVD having discontinuous Medicaid cov-
erage had higher hospital, and lower primary care utilization than their counterparts 
with continuous Medicaid coverage. Medicaid programs will greatly benefit from 
implementing provisions that mitigate coverage instability and associated disrup-
tions in continuity of care.
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objeCtives: Diabetic nephropathy is the leading cause of chronic kidney dis-
ease in the United States and is associated with increased mortality. A quality 
measure that contributes to a CMS Star Rating is that patients with hypertension 
and diabetes receive a renin-angiotensin system (RAS) inhibitor. The objective 
of this study was to compare the impact of a Diabetes Treatment Management 
(DTM) Program, aimed to improve the compliance of appropriate RAS inhibitors 
for diabetic patients, between dual eligible (DE) and non-DE Medicare Advantage 
beneficiaries. Methods: This was a retrospective study of pharmacy claims data 
among Medicare Advantage beneficiaries > 18 years of age in 2014. Members with 
one diabetic medication claim and one anti-hypertensive medication (calcium 
channel blockers or beta blockers) claim were included. The DTM program alerted 
the prescribing provider via fax to add a CMS recommended RAS inhibitor, if appro-
priate. Intervention success was defined when a recommended anti-hypertensive 
medication (renin angiotensin system antagonist, angiotensin converting enzyme, 
angiotensin receptor blocker, or direct renin inhibitor) was subsequently filled by 
the targeted member. Comparisons between groups were performed using the χ 2 
test. Results: This data represents 1,037,543 non-DE and 195,413 DE Medicare 
Advantage beneficiaries. A total of 32,154 members were eligible for the DTM 
program. Of these, 26,896 (84%) were among non-DE and 5,258 (16%) were among 
DE Medicare beneficiaries. The DTM program was successful in 26% of the overall 
population. The success rate was 27% (7,177/26,896) among non-DE compared 
to 23% (1,211/5,258) among DE Medicare beneficiaries receiving the intervention 
(p< 0.0001). ConClusions: The DTM program was more successful in the non-
DE than in the DE Medicare Advantage population. However, further research 
is needed to understand the factors behind the difference in success for these 
populations.
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objeCtives: The study aimed to compare the direct medical cost difference of 
hemorrhagic stroke inpatients with different types of health insurance from 2010 to 
2012 in China. Methods: A nationwide, cross-sectional sampling of hemorrhagic 
stroke inpatients with disease code ICD-10 (I60,I61,I62) with basic medical insurance 
scheme for employees (BMISE) and basic medical insurance scheme for urban resi-
dents (BMISUR) was extracted from the China Health Insurance Research Association 
claim database. A retrospective analysis was adopted. Results: The inpatients 
number of BMISE was 5321,the inpatients number of BMISUR was 1510. The average 
age was 63.08 and 62.34 years, respectively. Patients with BMISE went to third-level 
hospitals, second-level hospitals and under second-level hospitals accounted for 
57.01%, 33.71% and 9.27%; but for BMISUR, the percentage of distribution was 48.94%, 
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objeCtives: Standardized outcomes of global vascular disease (GVD) are dif-
ficult to obtain in middle income countries. Mortality and readmissions are 
regarded as important quality outcomes. We used the standardized results of 
a hospitalization study to obtain in-hospital mortality and readmissions at 365 
and 30 days. Methods: We developed a standardized registry from a cross-sec-
tional study (Value in Health 2011;14:A18). The universe of patients is all Clinical 
Classification Software Grouper, CCS #100-116 of hospital discharge minimum 
data set (MDS), 19 yrs old (GVD). The 30 day readmission (< 30 d ReH), defined as: 
the number of stays with at least one subsequent hospital stay within 30 days (n)/ 
the total number of hospital stays in the one year period observed (N), 365 day 
readmissions (365 ReH) follow the same definition with corresponding change in 
n. Denominator excluded < 19 years old and dead patients in index admission. 
Overall mortality (denominator all discharges) and case fatality rations (deaths /
each CCS or CCS group), rates and corresponding 95%CI are analyzed. Results: 
Among 45466 discharges, those with CCS #100-116 (11,02%) had 440 deaths ( mor-
tality 0,97% (95%CI 0,88-1,06%) , of this 5009 discharges the case fatality ratio was 
8,78% (95%CI 8,00-9,57%). A-VD events led to a < 30 ReH rate of 11,34% ( 95%CI 
10,46-12,21%) and a 365 days ReH rate of 40,75% (95%CI 39,49-42,11%). Among 
groups the highest case fatality ratio was that of cerebrovascular disorders: 16,79% 
(95%CI 14,22-19,35%); congestive heart failure showed the highest < 30 ReH rate: 
18,08% (95%CI 15,88-20,88%); and the highest 365 ReH rate 60,87% (95%CI 58,08-
63,65%). The most lethal CCS was #107: 91,04% (95%CI 84,21-97,88%), (all individual/ 
group results not provided here). ConClusions: After obtaining prevalence esti-
mates of major GVD using CCS groupers, a standardized methodology, we where 
able to obtain mortality, case fatality and and first readmission estimates for major 
cardiovascular discharges of the country.
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objeCtives: Little is known about the current practices of managing depres-
sion among the women with cardio-vascular conditions. Therefore, the cur-
rent study was conducted to identity types of depression treatment among the 
women with cardio-metabolic conditions using a nationally representative survey 
data. Methods: Using data of 2012 Medical Expenditure survey a retrospective 
cross sectional study was performed. The study sample consisted of 944 women 
aged 21 or older with depression and presence of any of the following cardio-met-
abolic conditions: hypertension, heart disease, and diabetes. Depression treatment 
was classified into three categories: 1) No treatment, 2) Antidepressant use only 
and 3) Psychotherapy with or without antidepressant. The differences in the rates 
of depression treatment by demographic, socio-economic, and health-status were 
analyzed using chi-square tests. Factors associated with depression treatment 
were identified using multinomial logistic regression. Results: A greater propor-
tion of women with cardio-metabolic conditions received only antidepressant as 
a primary depression treatment (55%), and combination therapy (24%), whereas, 
21% women did not receive any depression treatment. Women with co-existing 
anxiety (Adjusted odds ratio: AOR: 5.23, 95% CI: 2.37, 11.52), women with poor or 
fair mental health status (AOR: 4.43, 95% CI: 1.45, 13.47), and women with living in 
rural areas (AOR: 2.92, 95% CI: 1.21,7.05) were significantly more likely to receive 
psychotherapy with or without antidepressant. Whereas, women with lower than 
high school education and fair or poor physical health status were less likely to 
receive psychotherapy with or without antidepressant. Women with no usual 
source of care were significantly less likely to receive only antidepressant treat-
ment. ConClusions: Nearly one forth of women diagnosed with depression and 
cardio-metabolic condition(s) did not receive any treatment of depression. Given 
the adverse prognostic outcomes of depression in women with chronic conditions, 
healthcare policy should be designed to improve use of active treatment in women 
with cardio-metabolic conditions.
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objeCtives: Recent studies have reported that a very high number of hyperten-
sive patients’ discontinue their treatment which may be attributed to issues such 
as unattained blood pressure goals, adverse drug events, drug cost, or personal 
factors. Treatment modifications (TMs) – addition, uptitration, switching, and 
downtitration – are necessary to address these issues. This study assessed patterns 
of TMs across the antihypertensive drug classes (ADCs) used as first-line treat-
ment. We compared the rates of TM and time-to-TM across ADCs. Additionally, 
we determined the association between TM strategies and the likelihood of 
treatment discontinuation. Methods: This is a retrospective cohort study using 
the BlueCross-BlueShield of Texas commercial claims database (2008-2012). We 
identified TMs that occurred within one year of starting hypertension treatment. 
Patients who received a TM were followed for 12 months to determine if and 
when they discontinued treatment. Cox regression models were used to identify 
the likelihood of TM, time-to-TM, and the likelihood of treatment discontinua-
tion. Results: About 48.5% patients received at least one TM within one year of 
objeCtives: To summarize the pharmacoeconomics research articles published on 
diabetes and hypertension in India. Methods: A PubMed database was searched 
for pharmacoeconomics research on diabetes and hypertension in India. The articles 
that were published and were available on Pubmed database from the year 1990 to 
2014 were searched by using MeSH (Medical Subject Headings) terms viz., pharmaco-
economics, cost effective analysis, cost analysis, health care cost, economic analysis 
and cost of illness. All the studies shown in the search results were considered for 
the study irrespective of the type of pharmacoeconomic evaluation. Results: A 
total of 446 pharmacoeconomics research articles were found based on the MeSH 
terms. Out of 446, 15 (68.18%) studies were related to diabetes and 7 (31.82%) stud-
ies were related to hypertension. In India, most of the studies were conducted in 
Tamil Nadu state (n= 12, 54.54%) followed by Karnataka (n= 2, 9.09%), Chandigarh 
(n= 2, 9.09%), Kerala (n= 2; 9.09%), New Delhi (n= 1, 4.54%), Maharashtra (n= 1, 4.54%), 
Gujarat (n= 1, 4.54%) and Telangana state (n= 1, 4.54%). Most of the articles were 
published in between the year 2011-2014 (n= 10, 45.45%) followed by 2007-2010 (n= 6, 
27.27%) and 2000-2002 (n= 6, 27.27%). There were no published articles on pharma-
coeconomic studies from the year 2003 to 2006. ConClusions: The pharmacoeco-
nomic studies published in India are relatively less compared to that of developed 
countries. There is a need for furthering pharmacoeconomic research on the most 
prevalent chronic diseases such as diabetes and hypertension in India. Researchers 
should also gear-up to publish pharmacoeconomics related research in reputed 
journals with high impact factor.
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objeCtives: Diabetes is one of the most prevalent chronic diseases in the United 
States. The probability of developing diabetes is closely related to body mass index 
(BMI). This study investigated the population-specific likelihood of developing dia-
betes in relation to other obesity-related comorbidities (hypertension, stroke, and 
coronary heart disease (CHD)) in the United States from 2007 to 2010. Methods: Data 
from the National Health and Nutrition Examination Survey (NHANES), 2007-2010, 
were used to analyze the risks of diabetes. The probability of developing diabetes 
was estimated by fitting an exponential survival function to the age first diagnosed 
with diabetes and controlling for race (white, black, and other), BMI category (normal 
weight: 18.5-24.9 kg/m2, overweight: 25-29.9 kg/m2, and obese: ≥ 30 kg/m2), and prior 
diagnosis of stroke, CHD, and hypertension. Complex sampling design in the NHANES 
data was adjusted for in all analyses. Results: We found that males were more likely 
to develop diabetes compared with females. Races other than blacks and whites had 
the highest risk of diabetes. The likelihood of developing diabetes increased with 
BMI. Obese individuals had a two times higher risk than normal weight individu-
als for most gender and race groups. Among hypertension, stroke, and CHD, hyper-
tension was found to be the most highly correlated with diabetes risk. Individuals 
with hypertension were three times more likely to develop diabetes compared with 
individuals without any comorbid conditions. Using normal weight white females 
as an example, the probability of developing diabetes without any obesity-related 
comorbidity was 0.04% compared with 0.13% for individuals with hypertension. A 
similar pattern of diabetes risks was found in patients with both hypertension and 
stroke. ConClusions: Our results showed that the risk of diabetes increased with 
BMI category, and that individuals with hypertension were three times more likely to 
develop diabetes compared with individuals without any preexisting comorbidities.
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objeCtives: Aging population in India is growing faster than other countries in 
the world. Aging impairs functional independence, impact activities of daily living 
(ADLs) and reduces quality of life. The goal of this study was to assess functional 
status and ADLs among aging population of India. Methods: The Longitudinal 
Aging Study in India (LASI) data was used to assess functional status and ADLs in 
elderly population. Data collected as part of LASI questionnaire on self-reported 
and European health scale, and Wallace and Herzog ADL scale was analyzed for 
descriptive statistics and for differences using the Chi square test and ANOVA. A 
regression analysis was performed to identify relationships between demographic 
characteristics, functional status and ADLs. A p value of < 0.05 was considered 
statistically significant. Results: A total of 1,683 older adults of 950 randomly sam-
pled households were included in this study. Hypertension, heart disease, stroke, 
lung disease, arthritis and psychiatric conditions were more prevalent with signifi-
cant regional differences (p< 0.05). Forty percent of respondents had work limiting 
health conditions. Respondents reporting poor health ranged between 18%-26% 
on two different health scales. Majority of the respondents reported difficulty with 
one or more of the five activities such as difficulty in bathing and getting in and 
out of the bed. Differences in functional status and ADLs were significant among 
respondents from four different states. Thirty six percent respondents from Kerala 
had work limiting health conditions and 40% from Karnataka had difficulty with 
ADLs (p< 0.05). Regression analysis showed significant relationship between arthri-
tis, lung disease, health condition limiting work, region of residence and difficulty 
with ADLs (p< 0.05). ConClusions: There are significant differences in functional 
status and ADLs among aging population of India. The findings of this study can 
help policy makers to design and implement interventions and policies that help 
elderly to improve ADLs.
